Keywords : ASEPSIS scores
An evaluation of the effectiveness of dermabrasion in the treatment of external ulcers using a randomized controlled trial
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 4, Pages 3189-3197
Background: Management of ulcers is a significant topic. Debridement of non-viable tissues, edema reduction, adequate dressing, and antibiotics if needed are fundamental ulcer management treatments. Disease control, Cover wounds with grafts or flaps. Bioburden is reduced via debridement to prepare the wound for healing. Without debridement, a wound is exposed to cytotoxic stimuli and competes for oxygen and nutrients with pathogens. Dermabrasion treats post-acne scars, naevi, sebaceous adenomas, and burns.
Aim & Objectives:
In this investigation, dermabrasion will be used to debride ulcers. Assess the usefulness and consequences of dermabrasion in ulcer care.
To compare dermabrasion to traditional treatment.
Assess wound healing.
Days in hospital Incision pain.
Materials and Methods: From the 120 patients presenting to outpatient clinic or admitted into the hospital with an ulcer on the extremity were recruited into the study.
Results: The mean VAS scores in this study were 5.11 ±1.31 in the conventional group and 2.52 1.089 in the trial group. The mean WOUND scores in this study were 13.97± 2.026 in the conventional group and 12.13 ±2.901 in the trial group. In terms of Wound scores, there was no statistically significant difference between the two groups (p=0.139). The mean ASEPSIS scores in this study were 47.89± 2.091 in the conventional group and 45.42 ±2.29 in the trial group. In terms of Wound scores, there was no statistically significant difference between the two groups (p=0.301).
Conclusion: Dermabrasion dramatically reduce discomfort during the surgery, enhances granulation and shortens healing time without injuring normal tissue or causing problems.